Our core team combines biopharma science, BD&L and business process,
biopharma data/analytics leadership, and tech startup experience.
Founder and CEO
20 years experience helping biotech and pharma companies apply data, analytics and technology in R&D and BD&L
PhD Neuroscientist with 16 years BD&L experience in industry, startups and academia
Head of Methodology
PhD in Genetics / Biochemistry, MBA in Finance, 18 years with Lilly
Head of Operations
20 years of experience in biotech & biopharma: drove scientific and business results
20 years leading projects in Marketing and IT
Certified Public Accountant serving various companies as strategic CFO
Chief Operating Officer, Arcellx, Clinical-Stage adaptable and controllable cell therapies for cancer and autoimmune diseases.
MD/PhD/FACP. Holds C-Level Executive Roles including various advisory, consulting and board positions with biotech, biopharma and clinical-stage therapeutics.
Senior Biotech Analyst
CFA Charterholder with 10+ years of experience in equity research covering therapeutics on the sellside, buyside and industry. Studied finance at NYU Stern and molecular biology at UC Berkeley
Small business owner, 10 years